The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 343:1425 November 9, 2000 Number 19
NextNext

Engineering the Human Germline: An exploration of the science and ethics of altering the genes we pass to our children

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Gregory Stock and John Campbell. 169 pp. New York, Oxford University Press, 2000. $29.95. ISBN 0-19-513302-1.

Let's dispense with the suspense. This is a short, readable, thought-provoking book that discusses in nontechnical terms the future of humankind in the age of genetic engineering and should be read by anyone who wishes to participate in a public discourse that will shape the future. The central topic is the technology of genetically altering germ-line cells. Altering germ-line cells, which produce ova and spermatozoa, is considerably different from altering somatic cells. Germ-line changes will affect every cell in the body and will be passed on to future generations, whereas somatic-cell changes affect only specific cells within a given organ . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.